J. W. Meakin

2.0k total citations
37 papers, 1.4k citations indexed

About

J. W. Meakin is a scholar working on Endocrinology, Diabetes and Metabolism, Genetics and Oncology. According to data from OpenAlex, J. W. Meakin has authored 37 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Endocrinology, Diabetes and Metabolism, 12 papers in Genetics and 8 papers in Oncology. Recurrent topics in J. W. Meakin's work include Estrogen and related hormone effects (7 papers), Pituitary Gland Disorders and Treatments (6 papers) and Breast Cancer Treatment Studies (6 papers). J. W. Meakin is often cited by papers focused on Estrogen and related hormone effects (7 papers), Pituitary Gland Disorders and Treatments (6 papers) and Breast Cancer Treatment Studies (6 papers). J. W. Meakin collaborates with scholars based in Canada, United States and United Kingdom. J. W. Meakin's co-authors include George W. Thorn, Don H. Nelson, Dalmas H. Nelson, D. J. Sutherland, James B. Dealy, Donald D. Matson, Kendall Emerson, Damien Thomson, Nicholas Bruchovsky and T Germanson and has published in prestigious journals such as Science, New England Journal of Medicine and Annals of Internal Medicine.

In The Last Decade

J. W. Meakin

36 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. W. Meakin Canada 21 586 422 262 249 247 37 1.4k
Nancy B. McWilliams United States 22 431 0.7× 205 0.5× 257 1.0× 262 1.1× 628 2.5× 44 2.1k
Patricia Usher United States 13 286 0.5× 220 0.5× 369 1.4× 159 0.6× 234 0.9× 15 1.8k
Fredrika Pekonen Finland 30 1.4k 2.4× 292 0.7× 236 0.9× 426 1.7× 102 0.4× 65 2.5k
A. J. Moolenaar Netherlands 22 548 0.9× 298 0.7× 572 2.2× 79 0.3× 635 2.6× 53 1.5k
Fulgencio Gómez Switzerland 18 576 1.0× 126 0.3× 104 0.4× 223 0.9× 228 0.9× 46 1.2k
Michael Derwahl Germany 27 1.3k 2.3× 422 1.0× 168 0.6× 441 1.8× 276 1.1× 57 2.0k
Jean-Michel Bidart France 25 1.4k 2.4× 310 0.7× 174 0.7× 244 1.0× 568 2.3× 41 2.4k
K Ikekubo Japan 27 1.1k 1.9× 163 0.4× 56 0.2× 245 1.0× 292 1.2× 94 2.1k
Michael M. Ritter Germany 18 551 0.9× 124 0.3× 196 0.7× 131 0.5× 476 1.9× 43 1.2k
Edward J. Keenan United States 23 314 0.5× 869 2.1× 131 0.5× 355 1.4× 76 0.3× 46 2.0k

Countries citing papers authored by J. W. Meakin

Since Specialization
Citations

This map shows the geographic impact of J. W. Meakin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. W. Meakin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. W. Meakin more than expected).

Fields of papers citing papers by J. W. Meakin

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. W. Meakin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. W. Meakin. The network helps show where J. W. Meakin may publish in the future.

Co-authorship network of co-authors of J. W. Meakin

This figure shows the co-authorship network connecting the top 25 collaborators of J. W. Meakin. A scholar is included among the top collaborators of J. W. Meakin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. W. Meakin. J. W. Meakin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Foote, Matthew, Margaret McGrath, Alexander Guminski, et al.. (2014). Phase II study of single-agent panitumumab in patients with incurable cutaneous squamous cell carcinoma. Annals of Oncology. 25(10). 2047–2052. 124 indexed citations
2.
Panzarella, Tony & J. W. Meakin. (1998). Analysis of cause-specific failure endpoints using simple proportions: an example from a randomized controlled clinical trial in early breast cancer. International Journal of Radiation Oncology*Biology*Physics. 41(5). 1093–1097. 1 indexed citations
3.
Crump, Michael, Carol Sawka, Gerrit DeBoer, et al.. (1997). An individual patient-based meta-analysis of tamoxifen versus ovarian ablation as first line endocrine therapy for premenopausal women with metastatic breast cancer. Breast Cancer Research and Treatment. 44(3). 201–210. 49 indexed citations
4.
Sawka, Carol, Kathleen I. Pritchard, Wendy Shelley, et al.. (1997). A randomized crossover trial of tamoxifen versus ovarian ablation for metastatic breast cancer in premenopausal women: A report of the National Cancer Institute of Canada Clinical Trials Group (NCIC CTG) trial MA.1. Breast Cancer Research and Treatment. 44(3). 211–215. 30 indexed citations
5.
Meakin, J. W., J. L. Hayward, Tony Panzarella, et al.. (1996). Ovarian irradiation and prednisone following surgery and radiotherapy for carcinoma of the breast. Breast Cancer Research and Treatment. 37(1). 11–19. 31 indexed citations
6.
Sawka, C., Kathleen I. Pritchard, Alexander Paterson, et al.. (1986). Role and mechanism of action of tamoxifen in premenopausal women with metastatic breast carcinoma.. PubMed. 46(6). 3152–6. 86 indexed citations
7.
Knowling, Margaret A., et al.. (1982). Hypertrichosis lanuginosa acquisita associated with adenocarcinoma of the lung.. PubMed. 126(11). 1308–10. 11 indexed citations
8.
Boyd, Norman F., J. W. Meakin, J.L. Hayward, & Thomas C. Brown. (1981). Clinical estimation of the growth rate of breast cancer. Cancer. 48(4). 1037–1042. 24 indexed citations
9.
10.
Myers, Robert E., et al.. (1979). Prognostic Value of Postoperative Blood Levels of Carcinoembryonic Antigen (CEA) in Breast Cancer. Recent results in cancer research. 67. 26–32. 5 indexed citations
11.
Meakin, J. W., W. E. C. Allt, F. A. Beale, et al.. (1979). Ovarian Irradiation and Prednisone Following Surgery and Radiotherapy for Carcinoma of the Breast. Recent results in cancer research. 120(10). 118–122. 42 indexed citations
12.
Myers, Robert E., et al.. (1978). Carcinoembryonic antigen in breast cancer. Cancer. 42(S3). 1520–1526. 60 indexed citations
13.
Meakin, J. W.. (1972). Management of Juvenile Diabetes Mellitus.. Archives of Internal Medicine. 130(2). 301–301. 3 indexed citations
14.
Simpson, W. J., et al.. (1972). External irradiation of the hypophysis for Cushing's disease.. PubMed. 107(9). 860–2. 23 indexed citations
15.
Meakin, J. W.. (1968). A Biological Consideration of Treatment of Breast Cancer.. Archives of Internal Medicine. 122(4). 382–382. 16 indexed citations
16.
Meakin, J. W., et al.. (1960). Pituitary-adrenal function following long-term steroid therapy. The American Journal of Medicine. 29(3). 459–464. 34 indexed citations
17.
Meakin, J. W., et al.. (1959). THE RATE OF DISAPPEARANCE OF ACTH ACTIVITY FROM THE BLOOD OF HUMANS. The Journal of Clinical Endocrinology & Metabolism. 19(11). 1491–1495. 20 indexed citations
18.
Jenkins, J. S., J. W. Meakin, & Don H. Nelson. (1959). A COMPARISON OF THE INHIBITORY EFFECTS OF 2-METHYL-l,2-BIS(3-PYRIDYL)-l-PROPANONE AND AMPHENONE B ON ADRENAL CORTICAL SECRETION IN THE DOG1. Endocrinology. 64(4). 572–578. 37 indexed citations
19.
Nelson, Don H., J. W. Meakin, James B. Dealy, et al.. (1958). ACTH-Producing Tumor of the Pituitary Gland. New England Journal of Medicine. 259(4). 161–164. 235 indexed citations
20.
Jenkins, J. S., J. W. Meakin, Don H. Nelson, & George W. Thorn. (1958). Inhibition of Adrenal Steroid 11-Oxygenation in the Dog. Science. 128(3322). 478–480. 17 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Nancy B. McWilliams Breakdown of academic impact, for papers by Patricia Usher Breakdown of academic impact, for papers by Fredrika Pekonen Breakdown of academic impact, for papers by A. J. Moolenaar Breakdown of academic impact, for papers by Fulgencio Gómez Breakdown of academic impact, for papers by Michael Derwahl Breakdown of academic impact, for papers by Jean-Michel Bidart Breakdown of academic impact, for papers by K Ikekubo Breakdown of academic impact, for papers by Michael M. Ritter Breakdown of academic impact, for papers by Edward J. Keenan
Rankless by CCL
2026